[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] MARMOL I,SANCHEZ-DE-DIEGO C,PRADILLA DIESTE A,et al.Colorectal carcinoma:a general overview and future perspectives in colorectal cancer[J].Int J Mol Sci,2017,18(1):197.
[3] ZHANG Y,WANG Y,ZHANG B,et al.Methods and biomarkers for early detection,prediction,and diagnosis of colorectal cancer[J].Biomed Pharmacother,2023,163:114786.
[4] BILLER LH,SCHRAG D.Diagnosis and treatment of metastatic colorectal cancer:a review[J].JAMA,2021,325(7):669-685.
[5] JIANG M,LIU S,LIN J,et al.A pan-cancer analysis of molecular characteristics and oncogenic role of hexokinase family genes in human tumors[J].Life Sci,2021,264:118669.
[6] XIAO X,ZHANG Z,LUO R,et al.Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses[J].Oncol Lett,2021,21(5):363.
[7] DU R,HUANG C,LIU K,et al.Targeting AURKA in cancer:molecular mechanisms and opportunities for cancer therapy[J].Mol Cancer,2021,20(1):15.
[8] CIARDIELLO F,CIARDIELLO D,MARTINI G,et al.Clinical management of metastatic colorectal cancer in the era of precision medicine[J].CA Cancer J Clin,2022,72(4):372-401.
[9] WOLF AMD,FONTHAM ETH,CHURCH TR,et al.Colorectal cancer screening for average-risk adults:2018 guideline update from the American Cancer Society[J].CA Cancer J Clin,2018,68(4):250-281.
[10] YAN M,WANG C,HE B,et al.Aurora-A Kinase:a potent oncogene and target for cancer therapy[J].Med Res Rev,2016,36(6):1036-1079.
[11] BERDNIK D,KNOBLICH JA.Drosophila Aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis[J].Curr Biol,2002,12(8):640-644.
[12] ZHANG J,LI B,YANG Q,et al.Prognostic value of Aurora kinase A(AURKA) expression among solid tumor patients:a systematic review and meta-analysis[J].Jpn J Clin Oncol,2015,45(7):629-636.
[13] DUAN Z,CHINN D,TU MJ,et al.Novel synergistic combination of mitotic arrest and promotion of apoptosis for treatment of pancreatic adenocarcinoma[J].Transl Oncol,2019,12(4):683-692.
[14] SONG X,DU R,GUI H,et al.Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis[J].Oncol Rep,2020,43(1):133-146.
[15] HONG OY,KANG SY,NOH EM,et al.Aurora kinase A inducesmigration and invasion by inducing epithelial-to-mesenchymal transition in colon cancer cells[J].Beb Rep,2022,55(2):87-91.
[16] WANG LH,XIANG J,YAN M,et al.The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway[J].Cancer Res,2010,70(22):9118-9128.
[17] CHEN H,HU J,XIONG X,et al.AURKA inhibition induces Ewing's sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis[J].Cell Death Dis,2024,15(1):99.
[18] XIE Y,ZHU S,ZHONG M,et al.Inhibition of Aurora Kinase A induces necroptosis in pancreatic carcinoma[J].Gastroenterology,2017,153(5):1429-1443.e5.
[19] LI SS,ZHU HJ,LI JY,et al.MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level[J].Eur Rev Med Pharmacol Sci,2020,24(3):1126-1133.
[20] KABEKKODU SP,SHUKLA V,VARGHESE VK,et al.Clustered miRNAs and their role in biological functions and diseases[J].Biol Rev Camb Philos Soc,2018,93(4):1955-1986.
[21] GUO L,FU J,SUN S,et al.MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3[J].Cancer Sci,2019,110(2):805-816.
[22] GAO X,LAI Y,ZHANG Z,et al.Long non-coding RNA RP11-480I12.5 promotes the proliferation,migration,and invasion of breast cancer cells through the miR-490-3p-AURKA-Wnt/β-Catenin axis[J].Front Oncol,2020,10:948.
[23] ZHANG H,BAO J,ZHAO S,et al.MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene(AURKA) [J].Arch Med Sci,2019,16(2):395-406.
[24] WANG H,YANG G,YU Y,et al.MicroRNA-490-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells via targeting TMOD3[J].Oncol Lett,2020,20(4):95.